Press Releases

Date Title
01/05/18
Summary ToggleNeothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With Evofem Printer Friendly Version SAN DIEGO , Jan. 05, 2018 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that the Special Meeting of Stockholders held earlier today was convened and adjourned without any business being conducted other than the adjournment.  The meeting will reconvene on Wednesday, January 17,
11/08/17
Summary ToggleNeothetics Provides Business Update and Reports Third Quarter 2017 Financial Results Printer Friendly Version SAN DIEGO , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neothetics , Inc. (NASDAQ:NEOT) provided a business update and reported financial results for the third quarter 2017. Third Quarter 2017 and Recent Corporate Highlights In July 2017 , Neothetics announced that its Board of Directors unanimously approved
10/17/17
Summary ToggleNeothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company Printer Friendly Version SAN DIEGO, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) and Evofem Biosciences, Inc. today announced they have entered into a definitive agreement under which privately-held Evofem Biosciences will merge with a wholly-owned subsidiary of Neothetics in an all-stock transaction.
08/10/17
Summary ToggleNeothetics Provides Business Update and Reports Second Quarter 2017 Financial Results Printer Friendly Version SAN DIEGO , Aug. 10, 2017 (GLOBE NEWSWIRE) -- Neothetics , Inc. (NASDAQ:NEOT) provided a business update and reported financial results for the second quarter 2017. In July 2017 , Neothetics announced that its Board of Directors unanimously approved plans to initiate a process to explore and review
07/10/17
Summary ToggleNeothetics Announces Review of Strategic Alternatives Printer Friendly Version SAN DIEGO , July 10, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) announced today that its Board of Directors has unanimously approved plans to initiate a process to explore and review a range of strategic alternatives focusing on seeking an acquisition, business combination or
06/26/17
Summary ToggleNeothetics Announces Top-Line Results for Phase 2 Proof-of-Concept Study of LIPO-202 for the Reduction of Submental Subcutaneous Fat Printer Friendly Version LIPO-202 did not show efficacy in the reduction of submental fat SAN DIEGO , June 26, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced top-line safety and efficacy results
05/11/17
Summary ToggleNeothetics Provides Business Update and Reports First Quarter 2017 Financial Results Printer Friendly Version SAN DIEGO , May 11, 2017 (GLOBE NEWSWIRE) -- Neothetics , Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today provided a business update and reported financial results for the first quarter 2017.
05/04/17
Summary ToggleNeothetics to Provide a Business Update and Release First Quarter 2017 Financial Results Thursday, May 11th, 2017 Printer Friendly Version SAN DIEGO , May 04, 2017 (GLOBE NEWSWIRE) -- Neothetics , Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, announced today that it will provide a business update and release its first quarter 2017 financial results before the
04/05/17
Summary ToggleNeothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset Printer Friendly Version SAN DIEGO , April 05, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced the issuance of U.S. Patent Number 9,597,531 by the United States Patent and Trademark Office (USPTO). 
03/29/17
Summary ToggleNeothetics to Present at the 16th Annual Needham Healthcare Conference Printer Friendly Version SAN DIEGO , March 29, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that Susan A. Knudson , Neothetics’ Chief Financial Officer, will present at the 16 th Annual Needham Healthcare Conference on Wednesday, April 5 th at 12:50 PM ,  Eastern Time at the Westin Grand Central